MedTrace Logo

Glycemic Impact of Oatmeal Plus OatWellXF28

NCT02818452 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-12-07

No results posted yet for this study

Summary

The objective of this study is to determine the effect on glycemic responses of adding various doses of OatWell28XF to Quaker Instant Oatmeal in order to: 1) describe the dose-response curve and 2) If possible, identify the minimum level of OatWell28XF which, when added to a serving of Quaker Instant Oatmeal, would result in a glycemic response at least 20% less than that elicited by a β-glucan-free cereal.

Conditions

  • Glycemic Responses

Interventions

OTHER

Oatmeal + OatWell28XF

Intervention involves consumption of one cereal in the beginning of each visit of the crossover sequence

OTHER

Oatmeal

OTHER

Hot cereal

Sponsors & Collaborators

  • DSM Nutritional Products, Inc.

    collaborator INDUSTRY

  • PepsiCo Global R&D

    lead INDUSTRY

Principal Investigators

  • Thomas Wolever, MD · GI Laboratories

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02818452 on ClinicalTrials.gov